|
|
|
(Journal Article): Encapsulated, genetically modified cells producing in vivo therapeutics.
Hauser O, Prieschl-Grassauer E, Salmons B (Research Institute for Virology and Biomedicine, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria)
IN:
Curr Opin Mol Ther
2004; 6:412-420
Impact Factor(s) of Curr Opin Mol Ther: 3.117 (2004), 3.049 (2003), 2.463 (2002), 1.148 (2001)
ABSTRACT: The ability to implant genetically modified cells in immuno-isolating materials has much potential for therapeutic use. This review presents the different types of polymer that can be used for encapsulation of cells and the recent use of genetically modified, encapsulated and thus immunoprotected cells for the treatment of diseases in animal models and clinical trials. Some of the challenges faced by these technologies and potential solutions are also discussed.
TYPE OF PUBLICATION: Original article
Articles citing this article:
|
Respond
on this Journal Article!
Hint: Your Response should directly apply to Encapsulated, genetically modified cells producing in vivo therapeutics..
Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate
subject area. The actual subject area is Progenitors.
|
|
|
|
|
